中华老年医学杂志
中華老年醫學雜誌
중화노년의학잡지
Chinese Journal of Geriatrics
2008年
4期
259-261
,共3页
血压%脉压
血壓%脈壓
혈압%맥압
Blood pressure%Pulse pressure
目的 观察血脂康在老年高血压患者降压治疗中对血压和脉压的影响.方法 将经氨氯地平(5 mg,1次/d)降血压治疗后达到轻度高血压标准的老年高血压患者58例随机分为两组,血脂康组30例和对照组28例.对照组采用低脂、低盐饮食及按原剂量服用氨氯地平;血脂康组在此基础上加用血脂康600 mg,2次/d,连续服用12周,比较两组治疗前与治疗12周时血压和脉压的变化.结果 与治疗前比较,血脂康组治疗12周收缩压降低,分别为(149±9)mm Hg与(130±8)mm Hg;脉压缩小,分别为(64±11)mm Hg与(48±7)mm Hg(均为P＜0.05);12周时组间比较,血脂康组优于对照组,收缩压分别为(130±8)mm Hg与(144±9)mm Hg,脉压为(48±7)mm Hg与(60±10)mm Hg(均为P＜0.05).结论 老年高血压患者降压治疗中,应用常规剂量血脂康治疗可以起到降低血压的作用效应.
目的 觀察血脂康在老年高血壓患者降壓治療中對血壓和脈壓的影響.方法 將經氨氯地平(5 mg,1次/d)降血壓治療後達到輕度高血壓標準的老年高血壓患者58例隨機分為兩組,血脂康組30例和對照組28例.對照組採用低脂、低鹽飲食及按原劑量服用氨氯地平;血脂康組在此基礎上加用血脂康600 mg,2次/d,連續服用12週,比較兩組治療前與治療12週時血壓和脈壓的變化.結果 與治療前比較,血脂康組治療12週收縮壓降低,分彆為(149±9)mm Hg與(130±8)mm Hg;脈壓縮小,分彆為(64±11)mm Hg與(48±7)mm Hg(均為P＜0.05);12週時組間比較,血脂康組優于對照組,收縮壓分彆為(130±8)mm Hg與(144±9)mm Hg,脈壓為(48±7)mm Hg與(60±10)mm Hg(均為P＜0.05).結論 老年高血壓患者降壓治療中,應用常規劑量血脂康治療可以起到降低血壓的作用效應.
목적 관찰혈지강재노년고혈압환자강압치료중대혈압화맥압적영향.방법 장경안록지평(5 mg,1차/d)강혈압치료후체도경도고혈압표준적노년고혈압환자58례수궤분위량조,혈지강조30례화대조조28례.대조조채용저지、저염음식급안원제량복용안록지평;혈지강조재차기출상가용혈지강600 mg,2차/d,련속복용12주,비교량조치료전여치료12주시혈압화맥압적변화.결과 여치료전비교,혈지강조치료12주수축압강저,분별위(149±9)mm Hg여(130±8)mm Hg;맥압축소,분별위(64±11)mm Hg여(48±7)mm Hg(균위P＜0.05);12주시조간비교,혈지강조우우대조조,수축압분별위(130±8)mm Hg여(144±9)mm Hg,맥압위(48±7)mm Hg여(60±10)mm Hg(균위P＜0.05).결론 노년고혈압환자강압치료중,응용상규제량혈지강치료가이기도강저혈압적작용효응.
Objective To investigate the effect of Xuezhokang treatment on blood pressure and pulse pressure(PP) of elderly patients with primary hypertension(PH). Methods Fifty-eight elderly PH patients were treated with Amlodipine(5 mg/d).After the blood pressure were decreased to mild hypertension level,all the patients were randomly divided into 2 groups:30 patients in the Xuezhikang group,and 28 patients in the control group.The patients in the control group were treated with low fat and low salt diet and Amlodipine as before,and the patients in Xuezhikang group were treated not only with Xuezhikang 300 mg twice a day and Amlodipine as before for 12 weeks.Results The SBP and PP(mm Hg)were improved in both Xuezhikang and control groups,and Xuezhikang showed a better therapeutic effect(P＜0.05)than did the control.Xuezhikang group had SBP of(149±9,pretreatment)and(130±8,posttreatment),and PP of(64±11,pretreatment)and (48±7,posttreatment)(all P＜0.05).Control group showed SBP of(144±9)and(130±8)in pre-and post-treatment respectively,and showed PP of(60±10,pre-Rx)and(48±7,post-Rx)(all P＜0.05). Conclusions Anti-hypertensive medications in a routine dose combined with Xuezhikang have a better effect on the hypertension treatment in elderly patients.
